Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Director departure

CASI Pharmaceuticals, Inc (DE) (CASI) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/21/2021 8-K/A Quarterly results
09/25/2019 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/24/2018 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement, effective as of September 28, 2018, between the Company and George Chi"
04/04/2006 8-K/A Financial Statements and Exhibits
Docs: "Audited financial statements of Miikana for the Years Ended June 30, 2005 and June 30, 2004",
"Unaudited financial statements of Miikana for the Six Month Periods Ended December 31, 2005 and December 31, 2004",
"Unaudited pro forma combined financial information for the Year Ended December 31, 2005"
03/29/2006 8-K/A Financial Statements and Exhibits
Docs: "Consent of Reznick Group, P.C",
"Audited financial statements of Miikana for the Years Ended June 30, 2005 and June 30, 2004",
"Unaudited financial statements of Miikana for the Six Month Periods Ended December 31, 2005 and December 31, 2004",
"Unaudited pro forma combined financial information for the Year Ended December 31, 2005"
03/15/2002 8-K/A Financial statements and exhibits
Docs: "Item 7. Financial Statements, Pro Forma Information and Exhibits",
"License Agreement by and between Allergan Sales, Inc. and EntreMed, Inc., effective January 18, 2002* * Certain portions of this exhibit have been omitted based upon a request for confidential treatment. The omitted portions have been filed with the Commission pursuant to our application for confidential treatment"
03/11/2002 8-K/A Financial statements and exhibits
Docs: "Item 7. Financial Statements, Pro Forma Information and Exhibits",
"License Agreement by and between Allergan Sales, Inc. and EntreMed, Inc., effective January 18, 2002"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy